
Loading, please wait...

Loading, please wait...

Traditional bone grafts often struggle with the complex requirement of maintaining a functional blood supply and nervous system integration. However, recent research has introduced a transformative "bottom-up" approach to Vascularized Bone Tissue Engineering. By using modular microtissue units, scientists have successfully integrated angiogenesis and neurogenesis into a single tissue-engineered bone (TEB) construct. This innovation overcomes the limitations of traditional scaffolds that often lack the micro-architecture necessary for deep tissue survival and functional integration.
Researchers developed vascular-neural-bone microtissues using a three-dimensional (3D) coculture of bone marrow mesenchymal stem cells (BMSCs), endothelial progenitor cells (EPCs), and Schwann cells (SCs). Unlike top-down methods that seed cells onto large scaffolds, this bottom-up strategy uses these microtissues as building blocks. These units are encapsulated within gelatin methacrylate (GelMA) hydrogels to create large-scale grafts. Consequently, the resulting structure mimics the intricate vascular and neural networks found in natural bone tissue.
The study demonstrated that the GelMA/MSC/EPC/SC constructs significantly enhance angiogenesis, neurogenesis, and osteogenesis simultaneously. Molecular and cellular analysis confirmed the feasibility of this protocol across multiple levels of biological organization. This tri-lineage approach ensures that the newly formed bone is not only structurally sound but also physiologically active. Furthermore, the pre-vascularization aspect allows for faster anastomosis with the host circulatory system, which is critical for the clinical treatment of large-scale bone defects.
In the clinical setting, especially for complex fractures or tumor reconstructions in India, these findings offer a path toward more reliable bone grafts. The integration of Schwann cells promotes nerve regeneration, while EPCs drive the formation of essential capillary networks. Therefore, this multifunctional approach provides a comprehensive solution for patients suffering from critical-sized bone defects that typically resist standard healing processes.
Traditional bone grafting often relies on seeding cells onto a pre-made scaffold, which may not allow for deep cell penetration or complex vessel formation. The bottom-up approach uses tiny, pre-formed modular microtissues as building blocks to create a more naturally integrated and vascularized structure from the inside out.
Schwann cells are essential for neurogenesis. Including them ensures that the tissue-engineered bone develops a neural network alongside blood vessels. This crosstalk between nerves and bone is vital for proper bone metabolism and long-term functional recovery.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Cao G et al. Developing tissue-engineered bone with pre-vascularization and innervation using a bottom-up approach involving MSC/EPC/SC microtissues. Biofabrication. 2026 Feb 27. doi: 10.1088/1758-5090/ae4b6a. PMID: 41759217.
2. Annamalai RT et al. Multimodular vascularized bone construct comprised of vasculogenic and osteogenic microtissues. Biomaterials. 2019;189:63-73.
3. Nichol JW, Khademhosseini A. Modular tissue engineering: engineering biological tissues from the bottom up. Soft Matter. 2009;5(7):1312-1319.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed a bottom-up modular approach for bone regeneration using MSC/EPC/SC microtissues to integrate blood vessels and nerve fibers....
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today